Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyBørge G. Nordestgaard, M. John Chapman, Steve E. Humphries et al.|European Heart Journal|2013Cited by 2.7k
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementErik S.G. Stroes, Olov Wiklund|European Heart Journal|2015Cited by 1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Alberico L. Catapano, Gerald F. Watts et al.|European Heart Journal|2022Cited by 1.3k
Simvastatin with or without Ezetimibe in Familial HypercholesterolemiaJohn J.P. Kastelein, Eric de Groot, Fatima Akdim et al.|New England Journal of Medicine|2008Cited by 1.2k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyOlov Wiklund, Éric Bruckert, Robert A. Hegele et al.|European Heart Journal|2014Cited by 1.1k